Therefore, the present study aims to provide the comparative efficacies of different ALKIs in untreated Asian ALK-rearranged NSCLC patients, using network meta-analysis to retrieve efficacy profiles from trials that enrolled Asian subjects partially or exclusively. Here, ALK is linked to non-small cell lung carcinoma.